Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $808.67, a high ...

Initial results show a 17x increase in processing speed using NVIDIA H100 GPUs on NVIDIA DGX CloudParis, France – June xx 2025 – Cure51, the Techbio company on a mission to decode the biology of ...

Guangzhou Pharmaceutical Holdings Limited (GPHL), a Fortune Global 500 company, has taken a significant step forward in its ...

Hedge funds revealed their top investment ideas, from Chinese self-driving taxis to an Indian drug retailer, at the annual ...

CRL and CHDI Foundation extend their Huntington's disease partnership, boosting integration and global flexibility in drug discovery.

Elsewhere in Southeast Asia, the Thai baht strengthened 0.09% against the dollar to 32.59, while the Singapore dollar shed ...

The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass USD 20.5 billion by 2034. The surge in the prevalence of obesity ...

The FTSE 100 index closed up 55.93 points, 0.6%, at 8,772.38. The FTSE 250 ended up 30.43 points, 0.1%, at 21,028.01, and the AIM All-Share closed up 1.84 points, 0.3%, at 746.68.

AMT-130 has been granted the FDA’s Regenerative Medicine Advance Therapy (RMAT) designation and Breakthrough Therapy designation, the first therapy for Huntington’s disease to receive an RMAT ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...